Due to this eQTL effect, the higher proportion of APOE ε4 carriers among the patients with AD can lead to a decreased expression observed in the patients, explaining the reported association between the reduced APOE expression in astrocytes and the diagnosis of AD [27]. The gene discussed is APOE; the disease is Alzheimer disease.